Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors
Open accessAbstract
The mammalian CIP/KIP family of cyclin-dependent kinase (CDK) inhibitors (CKIs) comprises three proteins--p21(Cip1/WAF1), p27(Kip1), and p57(Kip2)--that bind and inhibit cyclin-CDK complexes, which are key regulators of the cell cycle. CIP/KIP CKIs have additional independent functions in regulating transcription, apoptosis and actin cytoskeletal dynamics. These divergent functions are performed in distinct cellular compartments and contribute to the seemingly contradictory observation that the CKIs can both suppress and promote cancer. Multiple ubiquitin ligases (E3s) direct the proteasome-mediated degradation of p21, p27 and p57. This review analyzes recent data highlighting our current understanding of how distinct E3 pathways regulate subpopulations of the CKIs to control their diverse functions.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
p21 levels in cells are controlled by mechanisms including the E3 ligases SCFSkp2, CRL4Cdt2, MDM2/X, CRL2LRR1, and APC/CCdc20.
“It is well known that p21 levels in cells are controlled by different mechanisms that include but are not exclusively restricted to the activity of the following E3 ligases: SCFSkp2, CRL4Cdt2, MDM2/X (or HDM2 in humans), CRL2LRR1, and APC/CCdc20.”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115 · see citing works
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
Glickman, M. H., & Ciechanover, A. J. (2002) · Physiological Reviews · doi:10.1152/physrev.00027.2001 · Cited by 4,216 · see citing works
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712 · see citing works
Function and regulation of cullin–RING ubiquitin ligases
Petroski, M. D., & Deshaies, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1547 · Cited by 2,148 · see citing works
PCNA, the Maestro of the Replication Fork
Moldovan, G.-L., Pfander, B., & Jentsch, S. (2007) · Cell · doi:10.1016/j.cell.2007.05.003 · Cited by 1,796 · see citing works
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,544 · see citing works
CDK inhibitors: Cell cycle regulators and beyond
Besson, A., Dowdy, S. F., & Roberts, J. M. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.013 · Cited by 1,152 · see citing works
Murray, A. W. (2004) · Cell · doi:10.1016/s0092-8674(03)01080-8 · Cited by 1,054 · see citing works
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
Chu, I. M., Hengst, L., & Slingerland, J. M. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2347 · Cited by 986 · see citing works
Liang, J., Shao, S. H., Xu, Z.-X., Hennessy, B. T., Ding, Z., Larrea, M. D., Kondo, S., Dumont, D. J., Gutterman, J. U., Walker, C. L., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1537 · Cited by 868 · see citing works
Duda, D. M., Borg, L. A., Scott, D. C., Hunt, H. W., Hammel, M., & Schulman, B. A. (2008) · Cell · doi:10.1016/j.cell.2008.07.022 · Cited by 767 · see citing works
Systematic analysis and nomenclature of mammalian F-box proteinsPreprint
Jin, J., Cardozo, T. J., Lovering, R. C., Elledge, S. J., Pagano, M., & Harper, J. W. (2004) · Genes & Development · doi:10.1101/gad.1255304 · Cited by 716 · see citing works
ADF/Cofilin: a functional node in cell biology
Bernstein, B. W., & Bamburg, J. R. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.001 · Cited by 704 · see citing works
Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation
Asada, M., Yamada, T., Ichijo, H., Delia, D., Miyazono, K., Fukumuro, K., & Mizutani, S. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1223 · Cited by 586 · see citing works
Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion
Narumiya, S., Tanji, M., & Ishizaki, T. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9170-7 · Cited by 530 · see citing works
Control of the SCFSkp2–Cks1 ubiquitin ligase by the APC/CCdh1 ubiquitin ligase
Bashir, T., Dorrello, N. V., Amador, V., Guardavaccaro, D., & Pagano, M. (2004) · Nature · doi:10.1038/nature02330 · Cited by 504 · see citing works
The cofilin pathway in breast cancer invasion and metastasis
Wang, W., Eddy, R. J., & Condeelis, J. S. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2148 · Cited by 487 · see citing works
Kamura, T., Maenaka, K., Kotoshiba, S., Matsumoto, M., Kohda, D., Conaway, R. C., Conaway, J. W., & Nakayama, K. I. (2004) · Genes & Development · doi:10.1101/gad.1252404 · Cited by 476 · see citing works
p21WAF1/Cip1: more than a break to the cell cycle?
Dotto, G. P. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00019-6 · Cited by 474 · see citing works
p21 and p27: roles in carcinogenesis and drug resistance
Abukhdeir, A. M., & Park, B. H. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000744 · Cited by 463 · see citing works
Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27Kip1 at G1 phase
Kamura, T., Hara, T., Matsumoto, M., Ishida, N., Okumura, F., Hatakeyama, S., Yoshida, M., Nakayama, K., & Nakayama, K. (2004) · Nature Cell Biology · doi:10.1038/ncb1194 · Cited by 413 · see citing works
CRL4s: the CUL4-RING E3 ubiquitin ligases
Jackson, S., & Xiong, Y. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.07.002 · Cited by 410 · see citing works
Dynamics of Cullin-RING Ubiquitin Ligase Network Revealed by Systematic Quantitative Proteomics
Bennett, E. J., Rush, A. J., Gygi, S. P., & Harper, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.11.017 · Cited by 386 · see citing works
p27 Phosphorylation by Src Regulates Inhibition of Cyclin E-Cdk2
Chu, I. M., Sun, J., Arnaout, A., Kahn, H., Hanna, W. M., Narod, S. A., Sun, P., Tan, C., Hengst, L., & Slingerland, J. M. (2007) · Cell · doi:10.1016/j.cell.2006.11.049 · Cited by 372 · see citing works
p27 kip1 independently promotes neuronal differentiation and migration in the cerebral cortexPreprint
Nguyen, L., Besson, A., Heng, J. I., Schuurmans, C. J., Teboul, L., Parras, C. M., Philpott, A., Roberts, J. M., & Guillemot, F. (2006) · Genes & Development · doi:10.1101/gad.377106 · Cited by 367 · see citing works
Skp2-Mediated Degradation of p27 Regulates Progression into Mitosis
Nakayama, K., Nagahama, H., Minamishima, Y. A., Miyake, S., Ishida, N., Hatakeyama, S., Kitagawa, M., Iemura, S.-I., Natsume, T., & Nakayama, K. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00131-5 · Cited by 364 · see citing works
Nuclear Accumulation of p21 Cip1 at the Onset of Mitosis: a Role at the G 2 /M-Phase Transition
Dulić, V., Stein, G. H., Far, D. F., & Reed, S. I. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.546 · Cited by 352 · see citing works
Cdk-Inhibitory Activity and Stability of p27 Are Directly Regulated by Oncogenic Tyrosine Kinases
Grimmler, M., Wang, Y., Mund, T., Cilenšek, Z., Keidel, E.-M., Waddell, M. B., Jäkel, H., Kullmann, M., Kriwacki, R. W., & Hengst, L. (2007) · Cell · doi:10.1016/j.cell.2006.11.047 · Cited by 337 · see citing works
The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2
Kamizono, S., Hanada, T., Yasukawa, H., Minoguchi, S., Kato, R., Minoguchi, M., Hattori, K., Hatakeyama, S., Yada, M., Morita, S., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010074200 · Cited by 311 · see citing works
Cullin-RING ubiquitin ligases: global regulation and activation cycles
Bosu, D. R., & Kipreos, E. T. (2008) · Cell Division · doi:10.1186/1747-1028-3-7 · Cited by 309 · see citing works
Self-citationTomoda, K., Kubota, Y., Arata, Y., Mori, S., Maeda, M., Tanaka, T., Yoshida, M., Yoneda‐Kato, N., & Kato, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104431200 · Cited by 307 · see citing works
Rodier, G., Montagnoli, A., Marcotullio, L. D., Coulombe, P., Draetta, G. F., Pagano, M., & Meloche, S. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6672 · Cited by 286 · see citing works
MDM2 Is a Negative Regulator of p21 , Independent of p53
Zhang, Z., Wang, H., Li, M., Agrawal, S., Chen, X., & Zhang, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312264200 · Cited by 253 · see citing works
Galea, C. A., Wang, Y., Sivakolundu, S. G., & Kriwacki, R. W. (2008) · Biochemistry · doi:10.1021/bi8006803 · Cited by 243 · see citing works
Kim, Y., Starostina, N. G., & Kipreos, E. T. (2008) · Genes & Development · doi:10.1101/gad.1703708 · Cited by 240 · see citing works
Self-citationUbiquitylation and proteasomal degradation of the p21 Cip1 , p27 Kip1 and p57 Kip2 CDK inhibitors
Lu, Z., & Hunter, T. R. (2010) · Cell Cycle · doi:10.4161/cc.9.12.11988 · Cited by 225 · see citing works
Mechanism of CRL4Cdt2, a PCNA-dependent E3 ubiquitin ligasePreprint
Havens, C. G., & Walter, J. C. (2011) · Genes & Development · doi:10.1101/gad.2068611 · Cited by 223 · see citing works
Huang, S., Shu, L., Dilling, M. B., Easton, J. B., Harwood, F. C., Ichijo, H., & Houghton, P. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00180-1 · Cited by 216 · see citing works
APC/CCdc20 Controls the Ubiquitin-Mediated Degradation of p21 in Prometaphase
Amador, V., Ge, S., Santamarı́a, P. G., Guardavaccaro, D., & Pagano, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.013 · Cited by 209 · see citing works
MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation
Jin, Y., Lee, H., Zeng, S. X., Dai, M., & Lu, H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg600 · Cited by 206 · see citing works
Lisztwan, J. H., Marti, A., Sutterlüty, H., Gstaiger, M., Wirbelauer, C., & Krek, W. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.368 · Cited by 203 · see citing works
Mahrour, N., Redwine, W. B., Florens, L., Swanson, S. K., Martin-Brown, S., Bradford, W. D., Staehling-Hampton, K., Washburn, M. P., Conaway, R. C., & Conaway, J. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706987200 · Cited by 196 · see citing works
Havens, C. G., & Walter, J. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.05.012 · Cited by 178 · see citing works
Cytoplasmic p21Cip1 Is Involved in Ras-induced Inhibition of the ROCK/LIMK/Cofilin Pathway
Lee, S., & Helfman, D. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306968200 · Cited by 163 · see citing works
Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis
Lee, E., Lee, M.-S., Camus, S., Ghim, J., Yang, M. R., Oh, W., Ha, N., Lane, D. P., & Song, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.164 · Cited by 158 · see citing works
p57KIP2: “Kip”ing the Cell under Control
Pateras, I. S., Apostolopoulou, K., Niforou, K., Kotsinas, A., & Gorgoulis, V. G. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0317 · Cited by 150 · see citing works
Abbas, T., & Dutta, A. (2011) · Cell Cycle · doi:10.4161/cc.10.2.14530 · Cited by 144 · see citing works
Stabilizers and Destabilizers Controlling Cell Cycle Oscillators
Guardavaccaro, D., & Pagano, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.017 · Cited by 116 · see citing works
Transcriptional Regulation during p21/-induced Apoptosis in Human Ovarian Cancer Cells
Wu, Q. J., Kirschmeier, P. T., Hockenberry, T., Yang, T., Brassard, D., Wang, L., McClanahan, T., Black, S., Rizzi, G., Musco, M. L., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204962200 · Cited by 116 · see citing works
p57Kip2 Regulates Actin Dynamics by Binding and Translocating LIM-kinase 1 to the Nucleus
Yokoo, T., Toyoshima, H., Miura, M., Wang, Y., Iida, K., Suzuki, H., Sone, H., Shimano, H., Gotoda, T., Nishimori, S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309334200 · Cited by 115 · see citing works
E6-associated protein (E6-AP) is a dual function coactivator of steroid hormone receptors
Ramamoorthy, S., & Nawaz, Z. (2008) · Nuclear Receptor Signaling · doi:10.1621/nrs.06006 · Cited by 109 · see citing works
Rodier, G., Coulombe, P., Tanguay, P., Boutonnet, C., & Meloche, S. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.6 · Cited by 106 · see citing works
Stabilization of MyoD by Direct Binding to p57Kip2
Reynaud, E. G., Leibovitch, M.-P., Tintignac, L. A. J., Pelpel, K., Guillier, M., & Leibovitch, S. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m907412199 · Cited by 104 · see citing works
Cul4A and DDB1 Associate with Skp2 To Target p27Kip1 for Proteolysis Involving the COP9 Signalosome
Bondar, T., Kalinina, A., Khair, L., Kopanja, D., Nag, A., Bagchi, S., & Raychaudhuri, P. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2531-2539.2006 · Cited by 103 · see citing works
Pirh2 Promotes Ubiquitin-Dependent Degradation of the Cyclin-Dependent Kinase Inhibitor p27 Kip1
Hattori, T., Isobe, T., Abe, K., Kikuchi, H., Kitagawa, K., Oda, T., Uchida, C., & Kitagawa, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2033 · Cited by 91 · see citing works
Li, B., Jia, N., Kapur, R., & Chun, K. T. (2006) · Blood · doi:10.1182/blood-2005-08-3349 · Cited by 89 · see citing works
UBE3A/E6-AP regulates cell proliferation by promoting proteasomal degradation of p27
Mishra, A., Godavarthi, S. K., & Jana, N. R. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.010 · Cited by 88 · see citing works
Suzuki, A., Kawano, H., Hayashida, M., Hayasaki, Y., Tsutomi, Y., & Akahane, K. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400706 · Cited by 84 · see citing works
A functional link between Wnt signaling and SKP2-independent p27 turnover in mammary tumorsPreprint
Miranda‐Carboni, G. A., Krum, S. A., Yee, K. M., Nava, M., Deng, Q., Pervin, S., Collado-Hidalgo, A., Galić, Z., Zack, J. A., Nakayama, K., et al. (2008) · Genes & Development · doi:10.1101/gad.1692808 · Cited by 83 · see citing works
Jin, Y., Zeng, S. X., Sun, X., Lee, H., Blattner, C., Xiao, Z. J., & Lu, H. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01198-07 · Cited by 79 · see citing works
PARC and CUL7 Form Atypical Cullin RING Ligase Complexes
Skaar, J. R., Florens, L. A., Tsutsumi, T., Arai, T., Tron, A. E., Swanson, S. K., Washburn, M. P., & DeCaprio, J. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3241 · Cited by 77 · see citing works
Chang, T.-S., Kim, M., Ryoo, K., Park, J., Eom, S. J., Shim, J., Nakayama, K., Nakayama, K., Takahashi, K., Lee, M.-J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309421200 · Cited by 74 · see citing works
Perucca, P., Cazzalini, O., Madine, M. A., Savio, M., Laskey, R. A., Vannini, V., Prosperi, E., & Stivala, L. A. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7507 · Cited by 71 · see citing works
State of the APC/C: Organization, function, and structure
McLean, J. R., Chaix, D., Ohi, M. D., & Gould, K. L. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.541420 · Cited by 70 · see citing works
Cyclin D2 Translocates p27 out of the Nucleus and Promotes Its Degradation at the G0-G1 Transition
Susaki, E. A., Nakayama, K., & Nakayama, K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00862-06 · Cited by 65 · see citing works
The cell cycle inhibitor p57Kip2 promotes cell death via the mitochondrial apoptotic pathway
Engskog‐Vlachos, P., Nyman, U., Hajji, N., & Joseph, B. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402158 · Cited by 62 · see citing works
Wang, B., Liu, K., Lin, H., Bellam, N., Ling, S., & Lin, W.-C. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01335-09 · Cited by 59 · see citing works
Starostina, N. G., Simpliciano, J. M., McGuirk, M. A., & Kipreos, E. T. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.10.013 · Cited by 58 · see citing works
Self-citationNishimori, S., Tanaka, Y., Chiba, T., Fujii, M., Imamura, T., Miyazono, K., Ogasawara, T., Kawaguchi, H., Igarashi, T., Fujita, T., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007499200 · Cited by 57 · see citing works
Disruption of TGF-β growth inhibition by oncogenic ras is linked to p27Kip1 mislocalization
Liu, X., Sun, Y., Ehrlich, M., Lu, T., Kloog, Y., Weinberg, R. A., Lodish, H. F., & Henis, Y. I. (2000) · Oncogene · doi:10.1038/sj.onc.1203991 · Cited by 57 · see citing works
p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1
Ng, C.-C., Arakawa, H., Fukuda, S., Kondoh, H., & Nakamura, Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206586 · Cited by 54 · see citing works
p57: A multifunctional protein in cancer (Review)
Nan, N. (2010) · International Journal of Oncology · doi:10.3892/ijo_00000617 · Cited by 53 · see citing works
The Cdk inhibitor p57Kip2 controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics
Engskog‐Vlachos, P., & Joseph, B. (2009) · Oncogene · doi:10.1038/onc.2009.269 · Cited by 50 · see citing works
Kim, J., Feng, H., & Kipreos, E. T. (2007) · Current Biology · doi:10.1016/j.cub.2007.04.055 · Cited by 48 · see citing works
Self-citationA new ubiquitin ligase involved in p57KIP2 proteolysis regulates osteoblast cell differentiation
Kim, M., Nakamoto, T., Nishimori, S., Tanaka, K., & Chiba, T. (2008) · EMBO Reports · doi:10.1038/embor.2008.125 · Cited by 39 · see citing works
Lee, J. G., & Kay, E. P. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0855 · Cited by 38 · see citing works
The p53‐inducible E3 ubiquitin ligase p53RFP induces p53‐dependent apoptosis
Huang, J., Xu, L., Liu, T., Zhai, Z., & Shu, H. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.09.105 · Cited by 37 · see citing works
The Initiation Step of Eukaryotic DNA Replication
Pospiech, H., Große, F., & Pisani, F. M. (2009) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-90-481-3471-7_5 · Cited by 34 · see citing works
Inflammation, antichymotrypsin, and lipid metabolism: autogenic etiology of alzheimer's disease
Janciauskiene, S. M., & Wright, H. T. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199812)20:12 · Cited by 24 · see citing works
Lukas, J., & Bártek, J. (2004) · Nature · doi:10.1038/432564a · Cited by 23 · see citing works
DNA replication licensing control and rereplication prevention
Li, C., & Jin, J. (2010) · Protein & Cell · doi:10.1007/s13238-010-0032-z · Cited by 14 · see citing works
Flagged first, then by citations
2 of the 83 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Roey, K. V., Uyar, B., Weatheritt, R. J., Dinkel, H., Seiler, M., Budd, A., Gibson, T. J., & Davey, N. E. (2014) · Chemical Reviews · doi:10.1021/cr400585q · Cited by 496 · see citing works
Barr, A. R., Cooper, S., Heldt, F. S., Butera, F., Stoy, H., Mansfeld, J., Novák, B., & Bakal, C. (2017) · Nature Communications · doi:10.1038/ncomms14728 · Cited by 403 · see citing works
Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs
Roskoski, R. J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.035 · Cited by 401 · see citing works
The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy
Kreis, N., Louwen, F., & Yuan, J. (2019) · Cancers · doi:10.3390/cancers11091220 · Cited by 309 · see citing works
Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs
Roskoski, R. J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.012 · Cited by 238 · see citing works
The influence of reactive oxygen species on cell cycle progression in mammalian cells
Verbon, E. H., Post, J. A., & Boonstra, J. (2012) · Gene · doi:10.1016/j.gene.2012.08.038 · Cited by 234 · see citing works
Patterns of Early p21 Dynamics Determine Proliferation-Senescence Cell Fate after Chemotherapy
Hsu, C.-H., Altschuler, S. J., & Wu, L. F. (2019) · Cell · doi:10.1016/j.cell.2019.05.041 · Cited by 181 · see citing works
The Transcription Factor FOXM1 (Forkhead box M1)
Wierstra, I. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407173-5.00004-2 · Cited by 174 · see citing works
Yonemori, K., Kurahara, H., Maemura, K., & Natsugoe, S. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.59 · Cited by 150 · see citing works
Wang, S., Gu, Y., Zebell, S. G., Anderson, L. K., Wang, W., Mohan, R., & Dong, X. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.10.005 · Cited by 125 · see citing works
Global Subcellular Characterization of Protein Degradation Using Quantitative Proteomics
Larance, M., Ahmad, Y., Kirkwood, K. J., Ly, T., & Lamond, A. I. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.024547 · Cited by 114 · see citing works
Less understood issues: p21Cip1 in mitosis and its therapeutic potential
Kreis, N., Louwen, F., & Yuan, J. (2014) · Oncogene · doi:10.1038/onc.2014.133 · Cited by 116 · see citing works
CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication
Mansilla, S. F., De La Vega, M. B., Calzetta, N. L., Siri, S. O., & Gottifredi, V. (2020) · Genes · doi:10.3390/genes11060593 · Cited by 114 · see citing works
Tang, H., Fan, X., Xing, J., Liu, Z., Jiang, B., Dou, Y., Gorospe, M., & Wang, W. (2015) · Aging · doi:10.18632/aging.100860 · Cited by 111 · see citing works
Distinct and overlapping functions of the cullin E3 ligase scaffolding proteins CUL4A and CUL4B
Hannah, J., & Zhou, P. (2015) · Gene · doi:10.1016/j.gene.2015.08.064 · Cited by 108 · see citing works
Li, X. L., Hara, T., Choi, Y., Subramanian, M., Francis, P., Bilke, S., Walker, R. L., Pineda, M. A., Zhu, Y. J., Yang, Y.-A., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01043-13 · Cited by 101 · see citing works
F-box protein interactions with the hallmark pathways in cancer
Randle, S. J., & Laman, H. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.09.013 · Cited by 95 · see citing works
The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations
Bisteau, X., Caldez, M. J., & Kaldis, P. (2014) · Cancers · doi:10.3390/cancers6010079 · Cited by 91 · see citing works
Preparation for DNA replication: the key to a successful S phase
Limas, J. C., & Cook, J. G. (2019) · FEBS Letters · doi:10.1002/1873-3468.13619 · Cited by 88 · see citing works
SIRT1 Is Downregulated in Gastric Cancer and Leads to G1-phase Arrest via NF-κB/Cyclin D1 Signaling
Yang, Q., Wang, B., Gao, W., Huang, S., Liu, Z., Li, W., & Jia, J. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0214 · Cited by 86 · see citing works
Functions of Ubiquitin and SUMO in DNA Replication and Replication Stress
García‐Rodríguez, N., Wong, R. P. C., & Ulrich, H. D. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00087 · Cited by 82 · see citing works
Naito, H., Wakabayashi, T., Kidoya, H., Muramatsu, F., Takara, K., Eino, D., Yamane, K., Iba, T., & Takakura, N. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2998 · Cited by 80 · see citing works
Tbx2 Controls Lung Growth by Direct Repression of the Cell Cycle Inhibitor Genes Cdkn1a and Cdkn1b
Lüdtke, T. H., Farin, H. F., Rudat, C., Schuster-Gossler, K., Petry, M., Barnett, P., Christoffels, V. M., & Kispert, A. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003189 · Cited by 79 · see citing works
Heldt, F. S., Barr, A. R., Cooper, S., Bakal, C., & Novák, B. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715345115 · Cited by 78 · see citing works
Persaud, S. D., Lin, Y.-W., Wu, C.-Y., Kagechika, H., & Wei, L. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.09.002 · Cited by 75 · see citing works
Noir, S., Marrocco, K., Masoud, K., Thomann, A., Gusti, A., Bitrián, M., Schnittger, A., & Genschik, P. (2015) · The Plant Cell · doi:10.1105/tpc.114.135301 · Cited by 71 · see citing works
p27 and Leukemia: Cell Cycle and Beyond
Roy, A., & Banerjee, S. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24819 · Cited by 64 · see citing works
Selective protein degradation: a rheostat to modulate cell-cycle phase transitions
Genschik, P., Marrocco, K., Bach, L., Noir, S., & Criqui, M. (2013) · Journal of Experimental Botany · doi:10.1093/jxb/ert426 · Cited by 60 · see citing works
Stat3 and C/EBPβ synergize to induce miR‐21 and miR‐181b expression during sepsis
McClure, C., McPeak, M. B., Youssef, D. A., Yao, Z. Q., McCall, C. E., & Gazzar, M. E. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.63 · Cited by 60 · see citing works
Lucas, T. F. G., Lazari, M. F. M., & Porto, C. S. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.09.015 · Cited by 59 · see citing works
Peng, Y., Zhu, Y., Yin, L., Zhang, J., Wei, J., Liu, X., Liu, X., Gao, W., Jiang, K., & Miao, Y. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0500-x · Cited by 57 · see citing works
Chen, Y., Liu, X., Wang, H., Liu, S., Hu, N., & Li, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01176 · Cited by 57 · see citing works
A p53-Responsive miRNA Network Promotes Cancer Cell Quiescence
La, T., Liu, G., Farrelly, M. L., Cole, N., Feng, Y., Zhang, Y. Y., Sherwin, S. K., Yari, H., Tabatabaee, H., Yan, X. G., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1886 · Cited by 56 · see citing works
Zhang, X., Kong, Y., Xu, X., Xing, H., Zhang, Y., Han, F., Li, W., Yang, Q., Zeng, J., Jia, J., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2183 · Cited by 53 · see citing works
Jones, T., da Silva, S. R., Bedolla, R. G., Ye, F., Zhou, F., & Gao, S. (2014) · Cell Cycle · doi:10.4161/cc.27758 · Cited by 52 · see citing works
Wang, X., Sun, D., Tai, J., & Wang, L. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7048 · Cited by 52 · see citing works
Coordination of cell growth and division by the ubiquitin–proteasome system
Benanti, J. A. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.04.005 · Cited by 51 · see citing works
All-trans Retinoic Acid as a Versatile Cytosolic Signal Modulator Mediated by CRABP1
Nagpal, I., & Wei, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153610 · Cited by 51 · see citing works
Pei, S., Wu, H., Huang, J., Xu, Y., Yang, F., Zhang, Q., & Xu, X. (2018) · Virus Research · doi:10.1016/j.virusres.2018.05.019 · Cited by 50 · see citing works
Cyclin-Dependent Kinase 4 and 6 Inhibitors in Cell Cycle Dysregulation for Breast Cancer Treatment
Susanti, N. M. P., & Tjahjono, D. H. (2021) · Molecules · doi:10.3390/molecules26154462 · Cited by 48 · see citing works
Lee, M.-S., Seo, J., Choi, D. Y., Lee, E.-W., Ko, A., Ha, N., Yoon, J., Lee, H. W., Kim, K. P., & Song, J. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.159 · Cited by 47 · see citing works
Antitumor mechanisms when pRb and p53 are genetically inactivated
Zhu, L., Lu, Z., & Zhao, H.-T. (2014) · Oncogene · doi:10.1038/onc.2014.399 · Cited by 47 · see citing works
Dubois, M., Selden, K., Bediée, A., Rolland, G., Baumberger, N., Noir, S., Bach, L., Lamy, G., Granier, C., & Genschik, P. (2018) · PLANT PHYSIOLOGY · doi:10.1104/pp.17.01712 · Cited by 46 · see citing works
Sheng, C., Mendler, I.-H., Rieke, S., Snyder, P., Jentsch, M., Friedrich, D., Drossel, B., & Loewer, A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.031 · Cited by 45 · see citing works
Rahmutulla, B., Matsushita, K., Satoh, M., Seimiya, M., Tsuchida, S., Kubo, S., Shimada, H., Ohtsuka, M., Miyazaki, M., & Nomura, F. (2013) · Oncotarget · doi:10.18632/oncotarget.1650 · Cited by 45 · see citing works
Jiang, D., & Aguiar, R. C. T. (2013) · Blood · doi:10.1182/blood-2013-07-515254 · Cited by 45 · see citing works
Lu, D., Han, C. Q., & Wu, T. (2013) · Oncogene · doi:10.1038/onc.2013.69 · Cited by 45 · see citing works
Zou, C., Chen, Y., Smith, R. M., Snavely, C. A., Li, J., Coon, T. A., Chen, B. B., Zhao, Y., & Mallampalli, R. K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.426882 · Cited by 44 · see citing works
The lowdown on breakdown: Open questions in plant proteolysis
Eckardt, N. A., Avin‐Wittenberg, T., Bassham, D. C., Chen, P., Chen, Q., Fang, J., Genschik, P., Ghifari, A. S., Guercio, A. M., Gibbs, D. J., et al. (2024) · The Plant Cell · doi:10.1093/plcell/koae193 · Cited by 44 · see citing works
Re-expression of cell cycle markers in aged neurons and muscles: Whether cells should divide or die?
Sharma, R. R., Kumar, D., Jha, N. K., Jha, S. K., Ambasta, R. K., & Kumar, P. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.09.010 · Cited by 43 · see citing works
Role of p27Kip1 as a transcriptional regulator
Bachs, O., Gallastegui, E., Orlando, S., Bigas, A., Morante‐Redolat, J. M., Serratosa, J., Fariñas, I., Aligué, R., & Pujol, M. J. (2018) · Oncotarget · doi:10.18632/oncotarget.25447 · Cited by 43 · see citing works
Pharmacological relevance of CDK inhibitors in Alzheimer's disease
Malhotra, N., Gupta, R. V., & Kumar, P. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105115 · Cited by 42 · see citing works
F-Box Protein Specificity for G1 Cyclins Is Dictated by Subcellular Localization
Landry, B. D., Doyle, J. P., Toczyski, D. P., & Benanti, J. A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002851 · Cited by 42 · see citing works
Swierzy, I. J., & Lüder, C. G. K. (2014) · Cellular Microbiology · doi:10.1111/cmi.12342 · Cited by 41 · see citing works
La, T., Chen, S., Guo, T., Zhao, X. H., Liu, T., Li, D., Carnell, M. J., Zhang, Y. Y., Feng, Y., Cole, N., et al. (2021) · Theranostics · doi:10.7150/thno.63763 · Cited by 41 · see citing works
Zhang, Y., Wang, J., Hui, B., Sun, W., Li, B., Shi, F., Che, S., Chai, L., & Song, L. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4057 · Cited by 40 · see citing works
Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation
Kreis, N., Friemel, A., Zimmer, B., Roth, S., Rieger, M. A., Rolle, U., Louwen, F., & Yuan, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10330 · Cited by 39 · see citing works
Barberis, M., Helikar, T., & Verbruggen, P. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00879 · Cited by 38 · see citing works
Hamajima, N., Johmura, Y., Suzuki, S., Nakanishi, M., & Saitoh, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075137 · Cited by 37 · see citing works
Yeganeh, M., Gui, Y., Kandhi, R., Bobbala, D., Tobelaim, W.-S., Saucier, C., Yoshimura, A., Ferbeyre, G., Ramanathan, S., & Ilangumaran, S. (2016) · Oncogene · doi:10.1038/onc.2015.485 · Cited by 37 · see citing works
Cell Cycle–Dependent Regulation and Function of ARGONAUTE1 in Plants
Trolet, A., Baldrich, P., Criqui, M., Dubois, M., Clavel, M., Meyers, B. C., & Genschik, P. (2019) · The Plant Cell · doi:10.1105/tpc.19.00069 · Cited by 37 · see citing works
Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
Selvaraju, K., Mofers, A., Pellegrini, P., Salomonsson, J., Ahlner, A., Morad, V., Hillert, E., Espinosa, B., Arnér, E. S. J., Jensen, L. D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46168-x · Cited by 36 · see citing works
Potential roles of longan flower and seed extracts for anti-cancer
Lin, C. (2012) · World Journal of Experimental Medicine · doi:10.5493/wjem.v2.i4.78 · Cited by 36 · see citing works
Role of the ubiquitin proteasome system in hematologic malignancies
Sahasrabuddhe, A. A., & Elenitoba‐Johnson, K. S. J. (2014) · Immunological Reviews · doi:10.1111/imr.12236 · Cited by 35 · see citing works
Nakatomi, M., Ida‐Yonemochi, H., & Ohshima, H. (2013) · Journal of Endodontics · doi:10.1016/j.joen.2012.12.016 · Cited by 32 · see citing works
Shangguan, J., Liang, C., Lian, M., Hongmin, C., Ronghua, T., Xiaoxuan, F., Binbin, Z., & Guo, S. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4499 · Cited by 31 · see citing works
Iskusnykh, I. Y., Buddington, R. K., & Chizhikov, V. V. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.05.015 · Cited by 30 · see citing works
Focal adhesion kinase antagonizes doxorubicin cardiotoxicity via p21Cip1
Cheng, Z., DiMichele, L. A., Rojas, M., Vaziri, C., Mack, C. P., & Taylor, J. M. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.12.002 · Cited by 29 · see citing works
Gentric, N., Masoud, K., Journot, R. P., Cognat, V., Chabouté, M., Noir, S., & Genschik, P. (2020) · PLANT PHYSIOLOGY · doi:10.1104/pp.20.00188 · Cited by 29 · see citing works
Molecular Mechanisms of DNA Replication Checkpoint Activation
Recolin, B., van der Laan, S., Tsanov, N., & Maiorano, D. (2014) · Genes · doi:10.3390/genes5010147 · Cited by 29 · see citing works
Podmirseg, S. R., Jäkel, H., Ranches, G., Kullmann, M. K., Sohm, B., Villunger, A., Lindner, H. H., & Hengst, L. (2016) · Oncogene · doi:10.1038/onc.2015.524 · Cited by 27 · see citing works
Tanaka, T., & Iino, M. (2013) · FEBS Journal · doi:10.1111/febs.12669 · Cited by 26 · see citing works
Roles of proteolysis in regulation of GPCR function
Cottrell, G. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02234.x · Cited by 26 · see citing works
Osaki, L. H., & Gama, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066651 · Cited by 26 · see citing works
p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer
Zhao, H.-T., Lu, Z., Bauzon, F., Fu, H., Cui, J., Locker, J. D., & Zhu, L. (2016) · Oncogene · doi:10.1038/onc.2016.175 · Cited by 25 · see citing works
p27 Kip1 V109G Polymorphism and Cancer Risk: A Systematic Review and Meta-Analysis
Wei, F., Xu, J., Tang, L., Shao, J.-Q., Wang, Y., Chen, L., & Guan, X. (2012) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2012.1229 · Cited by 26 · see citing works
CIZ1, a p21Cip1/Waf1‐interacting protein, functions as a tumor suppressor in vivo
Nishibe, R., Watanabe, W., Ueda, T., Yamasaki, N., Koller, R. P., Wolff, L., Honda, Z., Ohtsubo, M., & Honda, H. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.03.034 · Cited by 25 · see citing works
Jia, H., Cong, Q., Chua, J., Liu, H., Xia, X., Zhang, X., Lin, J., Habib, S. L., Ao, J., Zuo, Q., et al. (2014) · Oncogene · doi:10.1038/onc.2014.287 · Cited by 25 · see citing works
de Queiroz, R. M., Moon, S.-H., & Prives, C. L. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102289 · Cited by 24 · see citing works
Matsushita, K., Tamura, M., Tanaka, N., Tomonaga, T., Matsubara, H., Shimada, H., Levens, D., He, L., Liu, J., Yoshida, M., et al. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0673 · Cited by 24 · see citing works
Huang, K., Li, Z., Zhong, D., Yang, Y., Yan, X., Feng, T., Wang, X., Zhang, L., Shen, X., Chen, M., et al. (2023) · Advanced Science · doi:10.1002/advs.202300702 · Cited by 23 · see citing works
Zeng, L., Tang, M., Pi, C., Zheng, J., Gao, S., Chabanne, T., Chauvin, R., Cheng, W., Lin, H., Xu, R., et al. (2021) · Cancers · doi:10.3390/cancers13184677 · Cited by 22 · see citing works
Yang, V. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00008-6 · Cited by 21 · see citing works
Icaritin inhibits CDK2 expression and activity to interfere with tumor progression
Zhang, C., Wang, X., & Zhang, C. (2022) · iScience · doi:10.1016/j.isci.2022.104991 · Cited by 22 · see citing works
Santos, A. O., Parrini, M. C., & Camonis, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154840 · Cited by 22 · see citing works
Martín, J. M. P., Freire, P. F., Daimiel, L., Martı́nez-Botas, J., Martín-Sánchez, C., Lasunción, M. A., Peropadre, A., & Hazen, M. J. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.07.031 · Cited by 21 · see citing works
Proteasome inhibitors against amelanotic melanoma
Sidor-Kaczmarek, J., Cichorek, M., Spodnik, J. H., Wojcik, S. P., & Moryś, J. (2017) · Cell Biology and Toxicology · doi:10.1007/s10565-017-9390-0 · Cited by 20 · see citing works
Lewińska, A., Klukowska‐Rötzler, J., Deręgowska, A., Adamczyk‐Grochala, J., & Wnuk, M. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101163 · Cited by 20 · see citing works
Qiao, D., Meyer, K. K., & Friedl, A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00238-13 · Cited by 19 · see citing works
RetractedTargeting PSMD14 inhibits melanoma growth through SMAD3 stabilization
Yokoyama, S., Iwakami, Y., Zhao, H., Kin, R., Zhou, Y., Yasuta, Y., Takahashi, A., Hayakawa, Y., & Sakurai, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-76373-y · Cited by 19 · see citing works
Li, Y., Shi, F., Hu, J., Xie, L., Zhao, L., Tang, M., Luo, X., Ye, M., Zheng, H., Zhou, M., et al. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00153-8 · Cited by 19 · see citing works
p53-mediated G1 arrest requires the induction of both p21 and Killin in human colon cancer cells
Luo, D., Yu, C., Yu, J., Su, C., Li, S., & Liang, P. (2021) · Cell Cycle · doi:10.1080/15384101.2021.2014249 · Cited by 18 · see citing works
LncRNA LIMp27 Regulates the DNA Damage Response through p27 in p53‐Defective Cancer Cells
La, T., Chen, S., Zhao, X. H., Zhou, S. F., Xu, R., Liu, T., Zhang, Y. Y., Ye, K., Xu, L., Guo, T., et al. (2023) · Advanced Science · doi:10.1002/advs.202204599 · Cited by 18 · see citing works
Zanrè, V., Campagnari, R., Cerulli, A., Masullo, M., Cardile, A., Piacente, S., & Menegazzi, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031121 · Cited by 17 · see citing works
Zhang, J., Wu, Z., Savin, A., Yang, M., Hsu, Y.-H. R., Jantuan, E., Bacani, J. T. C., & Ingham, R. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-34199-9 · Cited by 17 · see citing works
CRL4 Ubiquitin Pathway and DNA Damage Response
Zhou, P., & Fan, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1025-0_14 · Cited by 14 · see citing works
Suzuki, S., Fukasawa, H., Misaki, T., Togawa, A., Ohashi, N., Kitagawa, K., Kotake, Y., Liu, N., Niida, H., Nakayama, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036249 · Cited by 16 · see citing works
Inhibitors of Cyclin-Dependent Kinase 1/2 for Anticancer Treatment
Mou, J., Chen, D., & Deng, Y. (2019) · Medicinal Chemistry · doi:10.2174/1573406415666190626113900 · Cited by 16 · see citing works
Tomi, E. D., Campagnari, R., Orlandi, E., Cardile, A., Zanrè, V., Menegazzi, M., Gomez‐Lira, M., & Gotte, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031647 · Cited by 15 · see citing works
The role of estrogen receptors in rat Sertoli cells at different stages of development
Macheroni, C., Lucas, T. F. G., & Porto, C. S. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05363 · Cited by 15 · see citing works
- Authors
- Starostina, N. G., & Kipreos, E. T.
- Affiliations
- University of Georgia (US)
- Corresponding author
- Starostina, Natalia G.
- Kipreos, Edward T.
- Venue
- Trends in Cell Biology
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 22
- Issue
- 1
- Pages
- 33-41
- ISSN
- 0962-8924 (ISSN-L)
- PMC
- PMC3298816
- OpenAlex
- W2149511654
- Cited by
- 147
- References
- 83
- Citations by year
- 2026: 8 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 8 · 2020: 9 · 2019: 13 · 2018: 11 · 2017: 9 · 2016: 15 · 2015: 8 · 2014: 15 · 2013: 24 · 2012: 10
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Trends in Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM055297, R01GM074212)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p21, p27, p57, ubiquitin ligase, E3 ubiquitin ligase, proteasomal degradation, protein degradation pathways, cell cycle regulation, transcriptional regulation, apoptosis, actin cytoskeleton dynamics
- MeSH terms
- Animals, Humans, Substrate Specificity, Transcription, Genetic, Apoptosis, Cyclin-Dependent Kinase Inhibitor Proteins, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review